XML 27 R6.htm IDEA: XBRL DOCUMENT v3.22.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
2 Months Ended 3 Months Ended 5 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2021
Mar. 31, 2021
Dec. 31, 2020
Sep. 30, 2021
Cash Flows from Operating Activities:          
Net loss $ (53,239) $ 1,915,923 $ 6,079,998 $ (2,958,534) $ (3,661,861)
Adjustments to reconcile net loss to net cash used in operating activities:          
General and administrative expenses paid by Sponsor under note payable 8,500     18,500  
Income earned on investments held in Trust Account 0 (4,534)   (325) (37,571)
Change in fair value of derivative warrant liabilities 0 (2,441,750)   2,355,500 2,298,250
Financing costs - derivative warrant liabilities       410,849  
Changes in operating assets and liabilities:          
Prepaid expenses       (509,248) 251,074
Accounts payable 11,264     61,811 212,708
Accrued expenses         1,500
Franchise tax payable 33,475     83,836 90,036
Net cash used in operating activities       (537,611) (845,864)
Cash Flows from Investing Activities          
Cash deposited in Trust Account       (175,950,000)  
Net cash used in investing activities       (175,950,000)  
Cash Flows from Financing Activities:          
Proceeds from note payable to related party       265,312  
Repayment of note payable to related party       (400,000)  
Proceeds received from initial public offering, gross       172,500,000  
Proceeds received from private placement       7,175,000  
Offering costs paid, net of reimbursement from underwriters       (1,810,475)  
Net cash provided by financing activities       177,729,837  
Net decrease in cash       1,242,226 (845,864)
Cash—beginning of the period     $ 1,242,226 1,242,226
Cash—end of the period   $ 396,362   1,242,226 $ 396,362
Supplemental disclosure of noncash financing activities:          
Offering costs paid in exchange for issuance of common stock to Sponsor 25,000     25,000  
Offering costs included in accrued expenses and accounts payable 120,357     70,000  
Offering costs included in accounts payable       234,907  
Offering costs included in note payable $ 78,781     116,188  
Deferred underwriting commissions in connection with the initial public offering       $ 6,900,000